Malvern Instruments and Netzsch Grinding & Dispersing Sign Agreement to Cooperate
Marketing agreement involves particle-sizing and milling equipment.
UK-based Malvern Instruments and Germany-based Netzsch Grinding & Dispersing have entered into a cooperative marketing agreement for a broad range of market sectors, including pharmaceuticals, announced Netzsch in an April 23 press release.
The global agreement, initially in place for three years, will harness the strength of each company’s brands and unique expertise in materials processing and materials characterization. Under the terms of the agreement, Netzsch will standardize on Malvern’s particle-sizing and characterization equipment, primarily the Mastersizer 3000 laser diffraction particle size analyzer. Customers and prospective customers of each company will gain access both to the extensive milling knowledge of the Netzsch teams and to the particle sizing know-how of Malvern Instruments.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
